{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR161/067/SRR16132067/SRR16132067_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR161/056/SRR16157056/SRR16157056_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR161/054/SRR16157054/SRR16157054_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR161/053/SRR16157053/SRR16157053_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR161/053/SRR16157053/SRR16157053_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR161/055/SRR16157055/SRR16157055_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR161/067/SRR16132067/SRR16132067_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR161/056/SRR16157056/SRR16157056_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR161/066/SRR16132066/SRR16132066_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR161/066/SRR16132066/SRR16132066_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR161/055/SRR16157055/SRR16157055_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR161/054/SRR16157054/SRR16157054_1.fastq.gz"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["The first affiliated hospital of USTC"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA767433"],"tag":["xref:EuropePMC:PMC8565356"],"long_description":["Evidence suggests that histone modification disorders are involved in leukemia pathogenesis. We previously reported that LukS-PV, a component of Panton-Valentine leukocidin (PVL), has anti-leukemia activities that can induce differentiation, increase apoptosis, and inhibit proliferation of acute myeloid leukemia (AML) cells. Furthermore, LukS-PV inhibited hepatoma progression by regulating histone deacetylation, speculating that LukS-PV may exert anti-leukemia activity by targeting histone modification regulators. In this study, the results showed that LukS-PV induced apoptosis by downregulating the methyltransferase SET8 and its target histone H4 monomethylated at Lys 20 (H4K20me1)"],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"","description":"LukS-PV induces AML cell apoptosis by targeting SET8.","dates":{"last_updated":"2023-05-19","first_public":"2021-10-18"},"accession":"PRJNA767433","cross_references":{}}